You are resident in a hospital in a very poor part of the world. Their drug selection is limited. A patient presents with acute cardiac failure, for which your preferred drug is dobutamine, given intravenously. However, there is none available. Which of the following other drugs, or combination of drugs, would be a suitable alternative?

Questions 106

ATI RN

ATI RN Test Bank

Peripheral Nervous System Drugs Questions

Question 1 of 5

You are resident in a hospital in a very poor part of the world. Their drug selection is limited. A patient presents with acute cardiac failure, for which your preferred drug is dobutamine, given intravenously. However, there is none available. Which of the following other drugs, or combination of drugs, would be a suitable alternative?

Correct Answer: D

Rationale: In this scenario, the correct alternative to dobutamine for acute cardiac failure when it is unavailable is option D, which is norepinephrine plus phentolamine. Norepinephrine is a vasopressor that can help increase blood pressure and cardiac output in cases of cardiac failure. Phentolamine is a non-selective alpha-adrenergic blocker that can help counteract the vasoconstrictive effects of norepinephrine. Option A, using dopamine at a very high dose, is not the best alternative as high doses of dopamine can lead to adverse effects such as tachycardia, arrhythmias, and increased myocardial oxygen demand, which can be detrimental in acute cardiac failure. Option B, using ephedrine alone, is not as effective as norepinephrine in increasing cardiac output and blood pressure in cases of acute cardiac failure. Option C, using ephedrine plus propranolol, is not a suitable alternative as propranolol is a beta-blocker that can further decrease cardiac output and worsen the condition in acute cardiac failure. In an educational context, understanding the mechanisms of action of these drugs and their effects on the cardiovascular system is crucial for making appropriate decisions in clinical practice, especially in resource-limited settings where drug choices may be restricted. It is essential to consider the hemodynamic effects and potential adverse reactions of different drugs when selecting alternatives in emergency situations like acute cardiac failure.

Question 2 of 5

A floor nurse pages you about a patient who is having a chest pain. You order an electro-cardiogram and rush to see the patient. He describes the pain as tight pressure and is demonstrably sweating and gasping for air. The ECG comes back with acute ST-segment elevations in inferior leads, and you diagnose a myocardial infarction. You start giving the patient oxygen and give him sublingual nitro-glycerin and morphine for pain. You also give him another medication, which you have read may prolong his survival in this situation. What class of medication is it?

Correct Answer: A

Rationale: The correct answer is A) ß-Blocker. In the scenario of a myocardial infarction, ß-Blockers are crucial in improving patient outcomes. ß-Blockers reduce myocardial oxygen demand by decreasing heart rate, blood pressure, and contractility, thereby reducing the workload of the heart during an acute event like a heart attack. They also help prevent arrhythmias and reduce the risk of future cardiac events. Option B) α-Agonist is incorrect because alpha agonists would increase blood pressure and heart rate, which can be detrimental in a myocardial infarction. Option C) Muscarinic agonist is incorrect because muscarinic agonists would lead to a decrease in heart rate and worsen the patient's condition during a myocardial infarction. Option D) Neuromuscular blocker is incorrect because it is used for muscle relaxation during surgeries and not indicated in the treatment of myocardial infarction. Understanding the pharmacological management of myocardial infarction and the rationale behind each medication choice is crucial for healthcare providers to provide optimal care to patients in acute settings. Understanding the mechanisms of action of different drug classes helps in making informed decisions and providing evidence-based care to improve patient outcomes.

Question 3 of 5

The following sympathomimetic drug is a catecholamine:

Correct Answer: D

Rationale: The correct answer is D) Isoprenaline. Isoprenaline is a catecholamine because it has a catechol nucleus in its chemical structure, which is a defining characteristic of catecholamines. Catecholamines are a class of sympathomimetic drugs that act on adrenergic receptors. Isoprenaline specifically acts on both beta-1 and beta-2 adrenergic receptors. Option A) Ephedrine is a sympathomimetic amine but is not a catecholamine. It is a mixed-acting sympathomimetic drug that primarily acts by releasing norepinephrine. Option B) Phenylephrine is a sympathomimetic amine that acts as a selective alpha-1 adrenergic receptor agonist. It is not a catecholamine because it lacks the catechol nucleus in its structure. Option C) Phentolamine is an alpha-adrenergic antagonist, not a sympathomimetic drug. It is used to block the effects of catecholamines like norepinephrine and epinephrine. Educationally, understanding the classification of drugs based on their chemical structure is crucial for pharmacology students and healthcare professionals. Knowing the differences between various sympathomimetic drugs helps in understanding their mechanisms of action, indications, contraindications, and potential side effects, which are vital in clinical practice for making informed decisions regarding drug therapy.

Question 4 of 5

Non-selective ß-blockers are contraindicated in:

Correct Answer: C

Rationale: The correct answer is C) Peripheral vascular disease. Non-selective ß-blockers block both ß1 and ß2 adrenergic receptors, leading to potential vasoconstriction in peripheral blood vessels. In patients with peripheral vascular disease, where there is already compromised blood flow to the extremities, the vasoconstrictive effect of non-selective ß-blockers can exacerbate the condition by further reducing blood flow. Option A) Angina of effort: Non-selective ß-blockers are commonly indicated in angina of effort due to their ability to reduce myocardial oxygen demand by decreasing heart rate and contractility. Option B) Systemic hypertension: Non-selective ß-blockers are often used to manage systemic hypertension by reducing cardiac output and renin-angiotensin-aldosterone system activation. Option D) Thyrotoxicosis: Non-selective ß-blockers can be beneficial in managing symptoms of thyrotoxicosis such as tachycardia and tremors by blocking the effects of excess thyroid hormones on the heart and peripheral vasculature. Educationally, understanding the contraindications of medications is crucial for clinical decision-making to ensure optimal patient outcomes. It is essential for healthcare professionals to be aware of the specific conditions in which certain medications should be avoided to prevent potential harm to patients.

Question 5 of 5

Each of the following parasympathomimetics is paired with an appropriate therapeutic use EXCEPT:

Correct Answer: D

Rationale: In this question, the correct answer is D) Parathion - organophosphorus poisoning. Parathion is not a parasympathomimetic drug but rather an organophosphorus compound used as an insecticide. Therefore, it is not paired with an appropriate therapeutic use like the other options which are actual parasympathomimetics. A) Physostigmine is used in the form of eye drops in glaucoma to constrict the pupil and reduce intraocular pressure by increasing outflow of aqueous humor. B) Neostigmine is used for postoperative retention of urine by promoting bladder emptying through the stimulation of the parasympathetic nervous system. C) Edrophonium is used in the diagnosis of myasthenia gravis to differentiate it from cholinergic crisis by temporarily improving muscle strength in myasthenia gravis patients. Understanding the appropriate therapeutic uses of parasympathomimetic drugs is crucial in clinical practice, especially in fields like ophthalmology, anesthesia, and neurology. It is important for healthcare professionals to be able to differentiate between various drugs and their indications to ensure safe and effective patient care.

Access More Questions!

ATI RN Basic


$89/ 30 days

ATI RN Premium


$150/ 90 days

Similar Questions